Nachrichten zur Hims & Hers Health Aktie

Morgan Stanley sets Overweight rating on Hims & Hers stock, cites growth potential…

Morgan Stanley bullish on Hims & Hers stock, sees 30% revenue growth ahead…

Morgan Stanley analyst Craig Hettenbach initiated coverage of Hims & Hers with an Overweight rating and $42 price target The…

State Street Corp increased its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by…

Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine…

Hims & Hers Health sees robust 2024 growth with $401.6-million Q3 revenues (+77% YoY), 2M+ subscribers and plans to exceed…

Hims & Hers Health, Inc. HIMS has emerged as a transformative player in the personalized healthcare market, showcasing robust growth…

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) has been given an average rating of "Hold" by the…

A new report from Hims & Hers underscores the urgency of weight loss for Americans as companies race to distribute…

…